XML 18 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated statements of cash flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:        
Net earnings $ 11,885 $ 7,712 $ 30,905 $ 30,022
Adjustments to reconcile net earnings to net cash provided by operating activities:        
Depreciation and amortization 8,169 7,711 24,168 22,524
Earnings from unconsolidated affiliates (2,960) (2,191) (6,940) (9,764)
Distributions from unconsolidated affiliates 4,457 7,510 12,663 15,462
Equity-based compensation 251 145 2,664 1,255
Amortization of deferred financing costs 204 167 614 607
Amortization of deferred revenue (108) (437) (428) (1,004)
Unrealized loss (gain) on derivative instruments (578) 461 557 551
Changes in operating assets and liabilities, net of effects from acquisitions and dispositions:        
Trade accounts receivable, net (1,950) 1,881 (2,949) 1,193
Due from affiliates (640) (55) (76) 409
Other current assets (788) 270 (793) 956
Amounts due under long-term terminaling services agreements, net (121) 388 (193) 727
Utility deposits 11   11  
Trade accounts payable 266 2,274 (1,570) 283
Due to affiliates (107) 105   220
Accrued liabilities 3,926 2,833 7,176 4,529
Net cash provided by operating activities 21,917 28,774 65,809 67,970
Cash flows from investing activities:        
Acquisition of terminal assets     (12,000)  
Investments in unconsolidated affiliates   (4,226) (2,225) (4,226)
Capital expenditures (10,139) (8,784) (34,105) (24,538)
Net cash used in investing activities (10,139) (13,010) (48,330) (28,764)
Cash flows from financing activities:        
Borrowings of debt under credit facility 35,400 26,000 140,200 64,000
Repayments of debt under credit facility (33,100) (33,400) (117,900) (66,400)
Deferred issuance costs (228) 5 (680) (1,356)
Distributions paid to unitholders (13,438) (12,624) (39,345) (37,871)
Purchase of common units by our long-term incentive plan       (92)
Contribution of cash by TransMontaigne GP 1   6  
Net cash used in financing activities (11,365) (20,019) (17,719) (41,719)
Increase (decrease) in cash and cash equivalents 413 (4,255) (240) (2,513)
Cash and cash equivalents at beginning of period     681 3,304
Cash and cash equivalents at end of period 441 791 441 791
Supplemental disclosures of cash flow information:        
Cash paid for interest 2,049 1,760 6,048 5,285
Property, plant and equipment acquired with accounts payable $ 9,295 $ 1,415 $ 9,295 $ 1,415